世界の胎児モニタリング市場(~2026年):製品別(超音波(3D&4D)、胎児電極、テレメトリデバイス、アクセサリ&消耗品)、携帯性別(携帯システム)、方法別(侵襲的)、用途別(分娩前)、エンドユーザー別(病院)

◆英語タイトル:Fetal Monitoring Market by Product (Ultrasound (3D & 4D), Fetal Electrodes, Telemetry Devices, Accessories and Consumables), Portability (Portable Systems), Method (Invasive), Application (Antepartum), End User (Hospitals) - Global Forecast to 2026
◆商品コード:MD3253
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年3月31日
◆ページ数:223
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は、世界の胎児モニタリング市場規模が2021年37億ドルから2026年52億ドルまで、年平均7.2%成長すると予測しています。本調査レポートでは、胎児モニタリングの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(超音波装置、母体/胎児電子モニター、胎児電極、胎児ドップラー装置、子宮収縮モニター)分析、携帯性別(非携帯システム、携帯システム)分析、方法別(非侵襲的方法、侵襲的方法)分析、用途別(分娩前、分娩中)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の胎児モニタリング市場規模:製品別(超音波装置、母体/胎児電子モニター、胎児電極、胎児ドップラー装置、子宮収縮モニター)
・世界の胎児モニタリング市場規模:携帯性別(非携帯システム、携帯システム)
・世界の胎児モニタリング市場規模:方法別(非侵襲的方法、侵襲的方法)
・世界の胎児モニタリング市場規模:用途別(分娩前、分娩中)
・世界の胎児モニタリング市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The global fetal monitoring market is projected to USD 5.2 billion by 2026 from USD 3.7 billion in 2021, at a CAGR of 7.2% from 2021 to 2026.”
The growth of this market is driven owing to the escalating prevalence of preterm births, favorable government policies, advanced technologies of fetal monitoring systems, and active product launches. Also, the development of noninvasive, portable, and advanced fetal monitors and emerging markets and strengthening infrastructure are anticipated to offer an opportunity for the growth of the market during the forecast period.

“Ultrasound Devices is expected to hold the largest share of the fetal monitoring market, by product in 2021.”
Based on products, the fetal monitoring market is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products. Ultrasound devices are the largest segment in this market. This segment’s growth can primarily be attributed to technological advancements, increasing congenital anomalies, maternal mortality, and rising regulatory approvals.

“Non-portable systems are expected to hold the largest share of the fetal monitoring market, by portability in 2021.”
Based on portability, the market is segmented into non-portable systems and portable systems. In 2020, non-portable systems accounted for the largest share of this market, owing to wide applications in hospitals and diagnostic centers to assess fetal and maternal health.

“Noninvasive is expected to hold the largest share of the fetal monitoring market, by method in 2021.”
Based on the method, the market is segmented into invasive and noninvasive. In 2020, the noninvasive accounted for the largest share of this market. Noninvasive methods are widely accepted for their safer method of diagnosing and monitoring the fetus, especially in high-risk pregnancies. The rising approvals of various noninvasive monitoring devices and the incoming advanced technologies drive the growth of this segment.

“Antepartum is expected to hold the largest share of the fetal monitoring market, by application in 2021.”
Based on application, the market is segmented into antepartum and intrapartum. The antepartum segment accounts for the largest share of the fetal monitoring market. Antepartum fetal monitoring is carried out throughout the gestation period to diagnose any congenital fetal abnormalities. The extensive monitoring regimes, recent product launches, surging prevalence of fetal anomalies, and maternal mortalities drive the growth of the antepartum segment.

“Hospitals are expected to hold the largest share of the fetal monitoring market, by end user in 2021.”
The market is segmented into hospitals, obstetrics & gynecology clinics, and home care settings based on end users. In 2020, hospitals accounted for the largest share of this market. This segment’s growth can be attributed to several factors, such as highly advanced facilities in hospitals and the increasing number of pregnancy procedures. Technological advancements, coupled with government funding, are also encouraging the installation of new tools and devices in hospitals, thus supporting market growth.

“North America commanded the largest share of the fetal monitoring market in 2021.”
On the basis of region, the fetal monitoring market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the fetal monitoring market. The large share of this market segment can be attributed to the presence of an established reimbufrsement structure coupled with availability of experts in the North American countries.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (33%), Europe (24%), AsiaPacific (27%), and Rest of the World (16%)

The some of the major players operating in this market are GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), FUJIFILM SonoSite, Inc. (US) and Cardinal Health, Inc. (US),

List of Companies Profiled in the Report
• Cardinal Health, Inc. (US)
• Koninklijke Philips N.V. (Netherlands)
• GE Healthcare (US)
• Siemens Healthineers (Germany)
• FUJIFILM SonoSite, Inc. (US)
• Natus Medical Incorporated (US)
• Huntleigh Healthcare Limited (UK)
• The Cooper Companies Inc. (US)
• CONTEC Medical Systems Co., Ltd. (China)
• EDAN Diagnostics, Inc. (China)
• Neoventa Medical AB (Sweden)
• Bionet Co., Ltd. (South Korea)
• Progetti Srl (Italy)
• TRISMED Co., Ltd. (Republic of Korea)
• ShenZhen Luckcome Technology Inc. (China)
• MedGyn Products, Inc (US)
• Dixion (Germany)
• Promed Group Co., Ltd. (Hong Kong)
• Advanced Instrumentations (US)
• BRAEL-Medical Equipment (Poland)
• GPC Medical (India)
• BISTOS (Korea)
• Mediana (Korea)
• Life Plus (India)
• ChoiceMMed (China)
• Trivitron Healthcare (India)
• Dott Medical Co. Ltd. (China)
• Shenzhen Comen Medical Instruments Co., Ltd. (China)
• Monarch Meditech (India)

Research Coverage
This report studies the fetal monitoring market based on product, portability, method, application, end user and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total fetal monitoring market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on fetal monitoring offered by the top 29 players in the fetal monitoring market. The report analyzes the fetal monitoring market product, portability, method, application, end user, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the fetal monitoring market
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the fetal monitoring market

Frequently asked questions
• What are the growth opportunities in the fetal monitoring market across major regions in the future?
• Which device is expected to hold the largest share in the fetal monitoring market?
• Which end user is anticipated to hold a considerable share in the fetal monitoring market?
• Which region has a well-developed fetal monitoring market?
• What is the impact of COVID-19 on fetal monitoring market?

【レポートの目次】

1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS 31
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
FIGURE 1 FETAL MONITORING MARKET SEGMENTATION 31
1.3.2 YEARS CONSIDERED FOR THE STUDY 32
1.4 CURRENCY 32
1.5 STAKEHOLDERS 32
1.6 SUMMARY OF CHANGES 33
1.7 LIMITATIONS 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 2 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 35
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 36
2.1.2.1 Key data from primary sources 37
2.1.2.2 Key industry insights 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 38
2.2 MARKET SIZE ESTIMATION 38
FIGURE 4 BOTTOM-UP APPROACH 39
FIGURE 5 APPROACH 3: PARENT MARKET ANALYSIS [NEONATAL CARE EQUIPMENT AND FETAL (LABOR & DELIVERY) MARKET] 40
FIGURE 6 APPROACH 4: PARENT MARKET ANALYSIS (ULTRASOUND MARKET) 40
FIGURE 7 APPROACH 5: PARENT MARKET ANALYSIS (HOME HEALTHCARE MARKET) 41
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42
FIGURE 9 TOP-DOWN APPROACH 42
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 43
FIGURE 10 DATA TRIANGULATION METHODOLOGY 43
2.4 MARKET SHARE ANALYSIS 44
2.5 ASSUMPTIONS FOR THE STUDY 44
2.6 COVID-19 ECONOMIC ASSESSMENT 44
2.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 45

3 EXECUTIVE SUMMARY 47
FIGURE 13 FETAL MONITORING MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION) 47
FIGURE 14 FETAL MONITORING MARKET, BY PORTABILITY, 2021 VS. 2026 (USD BILLION) 48
FIGURE 15 FETAL MONITORING MARKET, BY METHOD, 2021 VS. 2026 (USD BILLION) 48
FIGURE 16 FETAL MONITORING MARKET, BY APPLICATION, 2021 VS. 2026 (USD BILLION) 49
FIGURE 17 FETAL MONITORING MARKET, BY END USER, 2021 VS. 2026 (USD BILLION) 49
FIGURE 18 FETAL MONITORING MARKET, BY REGION, 2021 VS. 2026 (USD BILLION) 50
4 PREMIUM INSIGHTS 51
4.1 FETAL MONITORING MARKET OVERVIEW 51
FIGURE 19 THE RISING NUMBER OF PRETERM BIRTHS IS A MAJOR FACTOR DRIVING THE GROWTH OF THE FETAL MONITORING MARKET 51
4.2 NORTH AMERICA FETAL MONITORING MARKET SHARE, BY PORTABILITY (2020) 51
FIGURE 20 NON-PORTABLE SYSTEMS TO DOMINATE THE NORTH AMERICAN MARKET IN 2020 51
4.3 GEOGRAPHICAL SNAPSHOT OF THE FETAL MONITORING MARKET 52
FIGURE 21 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 22 FETAL MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 54
5.2.1.1 The rising number of preterm births and the increasing adoption of infertility treatments 54
5.2.1.2 Advanced and innovative fetal monitoring technologies 55
5.2.1.3 Government initiatives and increasing collaborations for research by health agencies 55
5.2.1.4 Reimbursements and insurance policies for fetal monitoring services 56
TABLE 1 CPT CODES FOR VAGINAL DELIVERIES 56
5.2.1.5 Active product launches by key manufacturers 57
5.2.2 RESTRAINTS 57
5.2.2.1 High costs of fetal monitoring equipment 57
5.2.2.2 Availability of refurbished products 57
5.2.3 OPPORTUNITIES 58
5.2.3.1 Development of noninvasive, portable, and advanced fetal monitors 58
5.2.3.2 Emerging markets and strengthening infrastructure 58
5.2.4 CHALLENGES 58
5.2.4.1 Product recalls 58
TABLE 2 PRODUCT RECALLS IN THE FETAL MONITORING MARKET 59

5.3 SUPPLY CHAIN ANALYSIS 59
FIGURE 23 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY OF PROMINENT COMPANIES 60
5.4 VALUE CHAIN ANALYSIS 60
FIGURE 24 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 60
5.5 ECOSYSTEM ANALYSIS 61
FIGURE 25 ECOSYSTEM ANALYSIS OF THE FETAL MONITORING INDUSTRY 61
5.5.1 ROLE IN THE ECOSYSTEM 62
5.6 REGULATORY LANDSCAPE 62
TABLE 3 LIST OF REGULATORY AUTHORITIES 63
5.6.1 EU REGULATIONS 63
5.6.2 US REGULATIONS 64
5.7 PORTER’S FIVE FORCES ANALYSIS 64
5.7.1 THREAT FROM NEW ENTRANTS 64
5.7.2 BARGAINING POWER OF SUPPLIERS 64
5.7.3 BARGAINING POWER OF BUYERS 65
5.7.4 INTENSITY OF COMPETITIVE RIVALRY 65
5.7.5 THREAT OF SUBSTITUTES 65
5.8 COVID-19 IMPACT ANALYSIS ON THE FETAL MONITORING MARKET 65
5.9 PATENT ANALYSIS 66
5.9.1 UTERINE CONTRACTION MONITORS 66
5.9.2 FETAL DOPPLERS 67
5.9.3 FETAL ELECTRODES 68
5.10 TRADE ANALYSIS (ULTRASOUND) 68
5.10.1 IMPORT DATA FOR ULTRASOUND (VALUE), BY COUNTRY,
2017–2019 (USD MILLION) 69
5.10.2 EXPORT DATA FOR ULTRASOUND (VALUE), BY COUNTRY,
2017–2019 (USD MILLION) 69
5.10.3 EXPORT DATA FOR ULTRASOUND (VOLUME), BY COUNTRY,
2017–2019 (KILOGRAMS) 70
5.10.4 IMPORT DATA FOR ULTRASOUND (VOLUME), BY COUNTRY,
2017–2019 (KILOGRAMS) 70
5.11 TECHNOLOGY ANALYSIS 70
5.12 AVERAGE SELLING PRICE TREND 71
TABLE 4 AVERAGE SELLING PRICE OF FETAL MONITORING PRODUCTS 71
6 FETAL MONITORING MARKET, BY PRODUCT 72
6.1 INTRODUCTION 73
TABLE 5 FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 73
6.2 ULTRASOUND DEVICES 73
TABLE 6 ULTRASOUND DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 74
TABLE 7 ULTRASOUND DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 74
6.2.1 2D ULTRASOUND 74
6.2.1.1 The increasing commercialization of innovative 2D technologies drives the growth of this segment 74
TABLE 8 FETAL MONITORING MARKET FOR 2D ULTRASOUND, BY REGION,
2019–2026 (USD MILLION) 75
6.2.2 3D & 4D ULTRASOUND 75
6.2.2.1 Technological advantages of 3D & 4D Ultrasound over 2D ultrasound to drive segment growth 75
TABLE 9 FETAL MONITORING MARKET FOR 3D & 4D ULTRASOUND, BY REGION, 2019–2026 (USD MILLION) 76
6.2.3 DOPPLER IMAGING 76
6.2.3.1 Doppler imaging analyzes fetal hemodynamics useful for fetal surveillance; key factor driving segment growth 76
TABLE 10 FETAL MONITORING MARKET FOR DOPPLER IMAGING, BY REGION,
2019–2026 (USD MILLION) 76
6.3 ELECTRONIC MATERNAL/FETAL MONITORS 77
6.3.1 THE RISING NUMBER OF HIGH-RISK PREGNANCIES AND THE REQUIREMENT OF ADVANCED FETAL MONITORING DEVICES TO ACCELERATE SEGMENT GROWTH 77
TABLE 11 ELECTRONIC MATERNAL/FETAL MONITORS MARKET, BY REGION,
2019–2026 (USD MILLION) 77
6.4 FETAL ELECTRODES 78
6.4.1 THE NEED FOR INTRAPARTUM FETAL SURVEILLANCE TO SUPPORT THE MARKET GROWTH OF THIS SEGMENT 78
TABLE 12 FETAL ELECTRODES MARKET, BY REGION, 2019–2026 (USD MILLION) 78
6.5 FETAL DOPPLER DEVICES 78
6.5.1 THE USE OF FETAL DOPPLERS IN-HOME CARE SETTINGS TO DRIVE SEGMENT GROWTH 78
TABLE 13 FETAL DOPPLER DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 79
6.6 UTERINE CONTRACTION MONITORS 79
TABLE 14 UTERINE CONTRACTION MONITORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 80
TABLE 15 UTERINE CONTRACTION MONITORS MARKET, BY REGION,
2019–2026 (USD MILLION) 80
6.6.1 INTERNAL UTERINE CONTRACTION MONITORS 80
6.6.1.1 The accurate measurement obtained by internal UCMs to propel segment growth 80
TABLE 16 INTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION,
2019–2026 (USD MILLION) 81
6.6.2 EXTERNAL UTERINE CONTRACTION MONITORS 81
6.6.2.1 The noninvasive nature of external UCMs is a factor supporting market growth 81
TABLE 17 EXTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION,
2019–2026 (USD MILLION) 81
6.7 TELEMETRY DEVICES 82
6.7.1 THE BENEFIT OF REMOTE MONITORING INCORPORATED INTO TELEMETRY DEVICES IS A MAJOR FACTOR DRIVING MARKET GROWTH 82
TABLE 18 TELEMETRY DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 82
6.8 ACCESSORIES AND CONSUMABLES 83
6.8.1 ADVANCEMENTS IN FETAL MONITORING TO LEAD TO THE INCREASING UTILIZATION OF ACCESSORIES AND CONSUMABLES 83
TABLE 19 ACCESSORIES AND CONSUMABLES MARKET, BY REGION,
2019–2026 (USD MILLION) 83
6.9 OTHER PRODUCTS 83
TABLE 20 OTHER PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION) 84
7 FETAL MONITORING MARKET, BY PORTABILITY 85
7.1 INTRODUCTION 86
TABLE 21 FETAL MONITORING MARKET, BY PORTABILITY, 2019-2026 (USD MILLION) 86
7.2 NON-PORTABLE SYSTEMS 86
7.2.1 TECHNOLOGICAL ADVANCEMENTS OF NON-PORTABLE SYSTEMS TO SUPPORT MARKET GROWTH 86
TABLE 22 NON-PORTABLE SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 86
7.3 PORTABLE SYSTEMS 87
7.3.1 REMOTE ACCURACY OFFERED BY PORTABLE SYSTEMS DRIVES THE MARKET GROWTH OF THIS SEGMENT 87
TABLE 23 PORTABLE SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 87
8 FETAL MONITORING MARKET, BY METHOD 88
8.1 INTRODUCTION 89
TABLE 24 FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION) 89
8.2 NONINVASIVE METHOD 89
8.2.1 NONINVASIVE METHODS ARE WIDELY ADOPTED IN HIGH-RISK PREGNANCIES, THUS DRIVING MARKET GROWTH 89
TABLE 25 NONINVASIVE MARKET, BY REGION, 2019–2026 (USD MILLION) 90
8.3 INVASIVE METHOD 90
8.3.1 CONSISTENT TRANSMISSION OF THE FETAL HEART RATE VIA INVASIVE METHODS SUPPORTS MARKET GROWTH 90
TABLE 26 INVASIVE MARKET, BY REGION, 2019–2026 (USD MILLION) 91
9 FETAL MONITORING MARKET, BY APPLICATION 92
9.1 INTRODUCTION 93
TABLE 27 FETAL MONITORING MARKET, BY APPLICATION, 2019-2026 (USD MILLION) 93
9.2 ANTEPARTUM 93
9.2.1 INCREASING INCIDENCES OF PREGNANCY-RELATED COMPLICATIONS TO SUPPORT GROWTH OF THIS SEGMENT 93
TABLE 28 ANTEPARTUM MARKET, BY REGION, 2019–2026 (USD MILLION) 94
9.3 INTRAPARTUM 94
9.3.1 FAVOURABLE GUIDELINES BY HEALTHCARE AUTHORITIES TO PROPEL GROWTH OF THE SEGMENT 94
TABLE 29 INTRAPARTUM MARKET, BY REGION, 2019–2026 (USD MILLION) 95

10 FETAL MONITORING MARKET, BY END USER 96
10.1 INTRODUCTION 97
TABLE 30 FETAL MONITORING MARKET, BY END USER, 2019-2026 (USD MILLION) 97
10.2 HOSPITALS 97
10.2.1 THE AVAILABILITY OF WELL-ESTABLISHED HEALTHCARE INFRASTRUCTURE DRIVES SEGMENT GROWTH 97
TABLE 31 FETAL MONITORING MARKET FOR HOSPITALS, BY REGION,
2019–2026 (USD MILLION) 98
10.3 OBSTETRICS & GYNECOLOGY CLINICS 98
10.3.1 THE RISING EMPHASIS ON PERINATAL CARE TO BOLSTER THE GROWTH OF THIS SEGMENT 98
TABLE 32 FETAL MONITORING MARKET FOR OBSTETRICS & GYNECOLOGY CLINICS,
BY REGION, 2019–2026 (USD MILLION) 99
10.4 HOME CARE SETTINGS 99
10.4.1 REMOTE-BASED CARE BY PORTABLE FETAL MONITORING SYSTEMS DRIVES THE GROWTH OF THIS END-USER SEGMENT 99
TABLE 33 FETAL MONITORING MARKET FOR HOME CARE SETTINGS, BY REGION,
2019–2026 (USD MILLION) 100
11 FETAL MONITORING MARKET, BY REGION 101
11.1 INTRODUCTION 102
TABLE 34 FETAL MONITORING MARKET, BY REGION, 2019–2026 (USD MILLION) 102
11.2 NORTH AMERICA 102
FIGURE 26 NORTH AMERICA: FETAL MONITORING MARKET SNAPSHOT 103
TABLE 35 NORTH AMERICA: FETAL MONITORING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 103
TABLE 36 NORTH AMERICA: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 104
TABLE 37 NORTH AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION) 104
TABLE 38 NORTH AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 104
TABLE 39 NORTH AMERICA: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 105
TABLE 40 NORTH AMERICA: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 105
TABLE 41 NORTH AMERICA: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 105
TABLE 42 NORTH AMERICA: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 105
11.2.1 US 106
11.2.1.1 The US held the largest share of the North American market in 2020 106
TABLE 43 ULTRASOUND CPT CODES (2019) 106
TABLE 44 US: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 107
TABLE 45 US: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,
BY TYPE, 2019–2026 (USD MILLION) 107
TABLE 46 US: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,
BY TYPE, 2019–2026 (USD MILLION) 108
TABLE 47 US: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 108
TABLE 48 US: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION) 108
TABLE 49 US: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 108
TABLE 50 US: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION) 109
11.2.2 CANADA 109
11.2.2.1 Growing government initiatives for fetal and maternal care to drive the market growth in Canada 109
TABLE 51 CANADA: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 110
TABLE 52 CANADA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION) 110
TABLE 53 CANADA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 110
TABLE 54 CANADA: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 111
TABLE 55 CANADA: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 111
TABLE 56 CANADA: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 111
TABLE 57 CANADA: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 111
11.3 EUROPE 112
TABLE 58 EUROPE: FETAL MONITORING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 112
TABLE 59 EUROPE: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 112
TABLE 60 EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,
BY TYPE, 2019–2026 (USD MILLION) 113
TABLE 61 EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 113
TABLE 62 EUROPE: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 113
TABLE 63 EUROPE: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 114
TABLE 64 EUROPE: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 114
TABLE 65 EUROPE: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 114
11.3.1 GERMANY 114
11.3.1.1 Increasing healthcare expenditure to support market growth in Germany 114
TABLE 66 GERMANY: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 115
TABLE 67 GERMANY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,
BY TYPE, 2019–2026 (USD MILLION) 116
TABLE 68 GERMANY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 116
TABLE 69 GERMANY: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 116
TABLE 70 GERMANY: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 117
TABLE 71 GERMANY: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 117
TABLE 72 GERMANY: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 117
11.3.2 UK 117
11.3.2.1 The rising emphasis towards better maternity services to drive market growth in the UK 117
TABLE 73 UK: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 118
TABLE 74 UK: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 75 UK: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,
BY TYPE, 2019–2026 (USD MILLION) 119
TABLE 76 UK: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 119
TABLE 77 UK: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION) 119
TABLE 78 UK: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 119
TABLE 79 UK: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION) 120
11.3.3 FRANCE 120
11.3.3.1 Increasing focus on healthcare policies to accelerate market growth during the forecast period 120
TABLE 80 FRANCE: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 121
TABLE 81 FRANCE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,
BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 82 FRANCE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 83 FRANCE: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 122
TABLE 84 FRANCE: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 122
TABLE 85 FRANCE: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 122
TABLE 86 FRANCE: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 122
11.3.4 ITALY 123
11.3.4.1 Increasing healthcare expenditure to propel the growth of the fetal monitoring market in Italy 123
TABLE 87 ITALY: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 123
TABLE 88 ITALY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,
BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 89 ITALY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 90 ITALY: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 124
TABLE 91 ITALY: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 124
TABLE 92 ITALY: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 124
TABLE 93 ITALY: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 125
11.3.5 SPAIN 125
11.3.5.1 Declining birth rate to restrain the growth of the market during the forecast period 125
TABLE 94 SPAIN: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 126
TABLE 95 SPAIN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 96 SPAIN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 97 SPAIN: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 127
TABLE 98 SPAIN: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 127
TABLE 99 SPAIN: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 127
TABLE 100 SPAIN: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 127
11.3.6 REST OF EUROPE 128
TABLE 101 ROE: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 128
TABLE 102 ROE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 103 ROE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 104 ROE: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 129
TABLE 105 ROE: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION) 130
TABLE 106 ROE: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 130
TABLE 107 ROE: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 130
11.4 ASIA PACIFIC 131
FIGURE 27 ASIA PACIFIC: FETAL MONITORING MARKET SNAPSHOT 131
TABLE 108 ASIA PACIFIC: FETAL MONITORING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 132
TABLE 109 ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 132
TABLE 110 ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,
BY TYPE, 2019–2026 (USD MILLION) 132
TABLE 111 ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 112 ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 133
TABLE 113 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 133
TABLE 114 ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 133
TABLE 115 ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 134
11.4.1 JAPAN 134
11.4.1.1 Increasing focus on the launch of innovative products to propel market growth in Japan 134
TABLE 116 JAPAN: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 135
TABLE 117 JAPAN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,
BY TYPE, 2019–2026 (USD MILLION) 135
TABLE 118 JAPAN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 135
TABLE 119 JAPAN: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 136
TABLE 120 JAPAN: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 136
TABLE 121 JAPAN: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 136
TABLE 122 JAPAN: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 136
11.4.2 CHINA 137
11.4.2.1 Developing healthcare infrastructure in China to support market growth 137
TABLE 123 CHINA: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 137
TABLE 124 CHINA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 125 CHINA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 126 CHINA: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 138
TABLE 127 CHINA: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 139
TABLE 128 CHINA: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 139
TABLE 129 CHINA: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 139
11.4.3 INDIA 139
11.4.3.1 The growing number of preterm births drives the market growth in India 139
TABLE 130 INDIA: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 140
TABLE 131 INDIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 132 INDIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 133 INDIA: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 141
TABLE 134 INDIA: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 142
TABLE 135 INDIA: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 142
TABLE 136 INDIA: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 142
11.4.4 SOUTH KOREA 142
11.4.4.1 Increasing awareness for the implementation of ultrasound technology to drive market growth in South Korea 142
TABLE 137 SOUTH KOREA: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 143
TABLE 138 SOUTH KOREA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,
BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 139 SOUTH KOREA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 140 SOUTH KOREA: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 144
TABLE 141 SOUTH KOREA: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 144
TABLE 142 SOUTH KOREA: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 144
TABLE 143 SOUTH KOREA: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 145
11.4.5 AUSTRALIA 145
11.4.5.1 Rising emphasis on maternal care to bolster market growth in Australia 145
TABLE 144 AUSTRALIA: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 146
TABLE 145 AUSTRALIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,
BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 146 AUSTRALIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 147 AUSTRALIA: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 147
TABLE 148 AUSTRALIA: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 147
TABLE 149 AUSTRALIA: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 147
TABLE 150 AUSTRALIA: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 147
11.4.6 REST OF ASIA PACIFIC 148
TABLE 151 ROAPAC: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 148
TABLE 152 ROAPAC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,
BY TYPE, 2019–2026 (USD MILLION) 148
TABLE 153 ROAPAC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 154 ROAPAC: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 149
TABLE 155 ROAPAC: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 149
TABLE 156 ROAPAC: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 149
TABLE 157 ROAPAC: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 150
11.5 REST OF THE WORLD 150
TABLE 158 REST OF THE WORLD: FETAL MONITORING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 150
TABLE 159 REST OF THE WORLD: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 151
TABLE 160 REST OF THE WORLD: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 161 REST OF THE WORLD: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 162 REST OF THE WORLD: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 152
TABLE 163 REST OF THE WORLD: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 152
TABLE 164 REST OF THE WORLD: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 152
TABLE 165 REST OF THE WORLD: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 153
11.5.1 MIDDLE EAST & AFRICA 153
11.5.1.1 A large number of pre-term births recorded in the MEA market drives the market growth in this region 153
TABLE 166 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 154
TABLE 167 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 168 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 169 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION) 155
TABLE 170 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 155
TABLE 171 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 155
TABLE 172 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 156
11.5.2 LATIN AMERICA 156
11.5.2.1 Favorable government policies to support the growth of the market 156
TABLE 173 LATIN AMERICA: FETAL MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 174 LATIN AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 175 LATIN AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 176 LATIN AMERICA: FETAL MONITORING MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 157
TABLE 177 LATIN AMERICA: FETAL MONITORING MARKET, BY METHOD,
2019–2026 (USD MILLION) 158
TABLE 178 LATIN AMERICA: FETAL MONITORING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 158
TABLE 179 LATIN AMERICA: FETAL MONITORING MARKET, BY END USER,
2019–2026 (USD MILLION) 158
12 COMPETITIVE LANDSCAPE 159
12.1 OVERVIEW 159
12.2 KEY PLAYER STRATEGIES 159
FIGURE 28 MARKET EVOLUTION MATRIX: JANUARY 2018 TO FEBRUARY 2021 160
12.3 MARKET SHARE ANALYSIS 160
FIGURE 29 FETAL MONITORING MARKET SHARE, BY KEY PLAYERS, 2019 161
12.4 COMPETITIVE EVALUATION MATRIX 162
12.4.1 STARS 162
12.4.2 EMERGING LEADERS 162
12.4.3 PERVASIVE 162
12.4.4 PARTICIPANTS 162
FIGURE 30 FETAL MONITORING MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 163
12.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES) 164
12.5.1 PROGRESSIVE COMPANIES 164
12.5.2 STARTING BLOCKS 164
12.5.3 RESPONSIVE COMPANIES 164
12.5.4 DYNAMIC COMPANIES 164
FIGURE 31 FETAL MONITORING MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2019 165
12.6 COMPANY PRODUCT FOOTPRINT 166
12.7 COMPANY GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE FETAL MONITORING MARKET 167
FIGURE 33 GEOGRAPHIC REVENUE MIX: FETAL MONITORING MARKET (2019) 167
12.8 COMPETITIVE SCENARIO 168

13 COMPANY PROFILES 171
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 KEY PLAYERS 171
13.1.1 GE HEALTHCARE 171
TABLE 184 GE HEALTHCARE: BUSINESS OVERVIEW 171
FIGURE 34 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT 172
13.1.2 SIEMENS HEALTHINEERS 174
TABLE 185 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 174
FIGURE 35 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT 174
13.1.3 CARDINAL HEALTH, INC. 177
TABLE 186 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 177
FIGURE 36 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT 177
13.1.4 KONINKLIJKE PHILIPS N.V. 179
TABLE 187 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 179
FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 179
13.1.5 FUJIFILM SONOSITE, INC. 183
TABLE 188 FUJIFILM SONOSITE, INC.: BUSINESS OVERVIEW 183
FIGURE 38 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 183
13.1.6 HUNTLEIGH HEALTHCARE LIMITED 187
TABLE 189 HUNTLEIGH HEALTHCARE LIMITED: BUSINESS OVERVIEW 187
FIGURE 39 ARJO: COMPANY SNAPSHOT 187
13.1.7 NATUS MEDICAL INCORPORATED 189
TABLE 190 NATUS MEDICAL INCORPORATED: BUSINESS OVERVIEW 189
FIGURE 40 NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT 189
13.1.8 THE COOPER COMPANIES INC. 191
TABLE 191 THE COOPER COMPANIES INC.: BUSINESS OVERVIEW 191
FIGURE 41 THE COOPER COMPANIES INC.: COMPANY SNAPSHOT 191
13.1.9 CONTEC MEDICAL SYSTEMS CO., LTD 193
TABLE 192 CONTEC MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW 193
13.1.10 EDAN DIAGNOSTICS, INC. 195
TABLE 193 EDAN DIAGNOSTICS, INC.: BUSINESS OVERVIEW 195
13.2 OTHER PLAYERS 197
13.2.1 NEOVENTA MEDICAL AB 197
TABLE 194 NEOVENTA MEDICAL AB: BUSINESS OVERVIEW 197
13.2.2 BIONET CO., LTD 198
TABLE 195 BIONET CO., LTD.: BUSINESS OVERVIEW 198
13.2.3 PROGETTI SRL 199
TABLE 196 PROGETTI SRL: BUSINESS OVERVIEW 199
13.2.4 TRISMED CO., LTD. 200
TABLE 197 TRISMED CO., LTD.: BUSINESS OVERVIEW 200
13.2.5 SHENZHEN LUCKCOME TECHNOLOGY INC. 201
TABLE 198 SHENZHEN LUCKCOME TECHNOLOGY INC.: BUSINESS OVERVIEW 201
13.2.6 MEDGYN PRODUCTS, INC. 203
TABLE 199 MEDGYN PRODUCTS, INC. BUSINESS OVERVIEW 203
13.2.7 DIXION 204
TABLE 200 DIXION: BUSINESS OVERVIEW 204
13.2.8 PROMED GROUP CO., LTD. 205
TABLE 201 PROMED GROUP CO., LTD.: BUSINESS OVERVIEW 205
13.2.9 ADVANCED INSTRUMENTATIONS 206
TABLE 202 ADVANCED INSTRUMENTATIONS: BUSINESS OVERVIEW 206
13.2.10 BRAEL-MEDICAL EQUIPMENT 207
TABLE 203 BRAEL-MEDICAL EQUIPMENT: BUSINESS OVERVIEW 207
13.2.11 GPC MEDICAL LTD. 208
TABLE 204 GPC MEDICAL: BUSINESS OVERVIEW 208
13.2.12 MONARCH MEDITECH 209
TABLE 205 MONARCH MEDITECH: BUSINESS OVERVIEW 209
13.2.13 BISTOS CO., LTD. 210
TABLE 206 BISTOS CO., LTD.: BUSINESS OVERVIEW 210
13.2.14 MEDIANA CO., LTD 211
TABLE 207 MEDIANA CO., LTD: BUSINESS OVERVIEW 211
13.2.15 LIFE PLUS MEDICAL 212
TABLE 208 LIFE PLUS MEDICAL: BUSINESS OVERVIEW 212
13.2.16 CHOICEMMED 213
TABLE 209 CHOICEMMED: BUSINESS OVERVIEW 213
13.2.17 TRIVITRON HEALTHCARE 214
TABLE 210 TRIVITRON HEALTHCARE: BUSINESS OVERVIEW 214
13.2.18 DOTT MEDICAL CO. LTD 216
TABLE 211 DOTT MEDICAL CO. LTD.: BUSINESS OVERVIEW 216
13.2.19 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD. 217
TABLE 212 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: BUSINESS OVERVIEW 217
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 218
14.1 INDUSTRY INSIGHTS 218
14.2 DISCUSSION GUIDE 219
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 225
14.4 AVAILABLE CUSTOMIZATIONS 227
14.5 RELATED REPORTS 227
14.6 AUTHOR DETAILS 228



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の胎児モニタリング市場(~2026年):製品別(超音波(3D&4D)、胎児電極、テレメトリデバイス、アクセサリ&消耗品)、携帯性別(携帯システム)、方法別(侵襲的)、用途別(分娩前)、エンドユーザー別(病院)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆